Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 131

1.

JNK2 in myeloid cells impairs insulin's vasodilator effects in muscle during early obesity development through perivascular adipose tissue dysfunction.

Meijer RI, Hoevenaars FPM, Serné EH, Yudkin JS, Kokhuis TJA, Weijers EM, van Hinsbergh VWM, Smulders YM, Eringa EC.

Am J Physiol Heart Circ Physiol. 2019 Aug 1;317(2):H364-H374. doi: 10.1152/ajpheart.00663.2018. Epub 2019 May 31.

PMID:
31149833
2.

Analogue insulin as an essential medicine: the need for more evidence and lower prices.

Beran D, Hemmingsen B, Yudkin JS.

Lancet Diabetes Endocrinol. 2019 May;7(5):338. doi: 10.1016/S2213-8587(19)30111-1. Epub 2019 Mar 22. No abstract available.

PMID:
30910501
3.

Combining Multiple Treatment Comparisons with Personalized Patient Preferences: A Randomized Trial of an Interactive Platform for Statin Treatment Selection.

Hopkin G, Au A, Collier VJ, Yudkin JS, Basu S, Naci H.

Med Decis Making. 2019 Apr;39(3):264-277. doi: 10.1177/0272989X19835239. Epub 2019 Mar 15.

PMID:
30873906
4.

Intermediate hyperglycaemia to predict progression to type 2 diabetes (ELSA-Brasil): an occupational cohort study in Brazil.

Schmidt MI, Bracco PA, Yudkin JS, Bensenor IM, Griep RH, Barreto SM, Castilhos CD, Duncan BB.

Lancet Diabetes Endocrinol. 2019 Apr;7(4):267-277. doi: 10.1016/S2213-8587(19)30058-0. Epub 2019 Feb 22.

PMID:
30803929
5.

Global public health starts at home: upstream approaches to global health training.

Oni T, Yudkin JS, Fonn S, Adongo P, Kaseje M, Ajuwon A, Doyal L, London L.

Lancet Glob Health. 2019 Mar;7(3):e301-e302. doi: 10.1016/S2214-109X(18)30558-8. No abstract available.

6.

Personalizing Second-Line Type 2 Diabetes Treatment Selection: Combining Network Meta-analysis, Individualized Risk, and Patient Preferences for Unified Decision Support.

Choi SE, Berkowitz SA, Yudkin JS, Naci H, Basu S.

Med Decis Making. 2019 Apr;39(3):239-252. doi: 10.1177/0272989X19829735. Epub 2019 Feb 15.

PMID:
30767632
7.

Estimation of global insulin use for type 2 diabetes, 2018-30: a microsimulation analysis.

Basu S, Yudkin JS, Kehlenbrink S, Davies JI, Wild SH, Lipska KJ, Sussman JB, Beran D.

Lancet Diabetes Endocrinol. 2019 Jan;7(1):25-33. doi: 10.1016/S2213-8587(18)30303-6. Epub 2018 Nov 21. Erratum in: Lancet Diabetes Endocrinol. 2019 Jan;7(1):e1.

PMID:
30470520
8.

Reducing chronic disease through changes in food aid: A microsimulation of nutrition and cardiometabolic disease among Palestinian refugees in the Middle East.

Basu S, Yudkin JS, Berkowitz SA, Jawad M, Millett C.

PLoS Med. 2018 Nov 20;15(11):e1002700. doi: 10.1371/journal.pmed.1002700. eCollection 2018 Nov.

9.

Support for UNRWA's survival.

Blanchet K, El-Zein A, Langer A, Sato M; 159 signatories.

Lancet. 2018 Sep 22;392(10152):1009-1010. doi: 10.1016/S0140-6736(18)32264-5. Epub 2018 Sep 12. No abstract available.

10.

Availability and Affordability of Essential Medicines: Implications for Global Diabetes Treatment.

Beran D, Ewen M, Lipska K, Hirsch IB, Yudkin JS.

Curr Diab Rep. 2018 Jun 16;18(8):48. doi: 10.1007/s11892-018-1019-z. Review.

PMID:
29907884
11.

Erratum. Why Are We Failing to Address the Issue of Access to Insulin? A National and Global Perspective. Diabetes Care 2018;41:1125-1131.

Beran D, Hirsch IB, Yudkin JS.

Diabetes Care. 2018 Sep;41(9):2048. doi: 10.2337/dc18-er09a. Epub 2018 Jun 15. No abstract available.

12.

Why Are We Failing to Address the Issue of Access to Insulin? A National and Global Perspective.

Beran D, Hirsch IB, Yudkin JS.

Diabetes Care. 2018 Jun;41(6):1125-1131. doi: 10.2337/dc17-2123. Erratum in: Diabetes Care. 2018 Jun 15;:.

PMID:
29784696
13.

Associations of stunting in early childhood with cardiometabolic risk factors in adulthood.

De Lucia Rolfe E, de França GVA, Vianna CA, Gigante DP, Miranda JJ, Yudkin JS, Horta BL, Ong KK.

PLoS One. 2018 Apr 11;13(4):e0192196. doi: 10.1371/journal.pone.0192196. eCollection 2018.

14.

Inequalities in non-communicable diseases in Israel.

Yudkin JS.

Lancet. 2018 Feb 10;391(10120):536-537. doi: 10.1016/S0140-6736(17)32473-X. No abstract available.

PMID:
29617238
15.

Validation of Risk Equations for Complications of Type 2 Diabetes (RECODe) Using Individual Participant Data From Diverse Longitudinal Cohorts in the U.S.

Basu S, Sussman JB, Berkowitz SA, Hayward RA, Bertoni AG, Correa A, Mwasongwe S, Yudkin JS.

Diabetes Care. 2018 Mar;41(3):586-595. doi: 10.2337/dc17-2002. Epub 2017 Dec 21.

16.

Development and validation of Risk Equations for Complications Of type 2 Diabetes (RECODe) using individual participant data from randomised trials.

Basu S, Sussman JB, Berkowitz SA, Hayward RA, Yudkin JS.

Lancet Diabetes Endocrinol. 2017 Oct;5(10):788-798. doi: 10.1016/S2213-8587(17)30221-8. Epub 2017 Aug 10.

17.

Diabetes in sub-Saharan Africa: from clinical care to health policy.

Atun R, Davies JI, Gale EAM, Bärnighausen T, Beran D, Kengne AP, Levitt NS, Mangugu FW, Nyirenda MJ, Ogle GD, Ramaiya K, Sewankambo NK, Sobngwi E, Tesfaye S, Yudkin JS, Basu S, Bommer C, Heesemann E, Manne-Goehler J, Postolovska I, Sagalova V, Vollmer S, Abbas ZG, Ammon B, Angamo MT, Annamreddi A, Awasthi A, Besançon S, Bhadriraju S, Binagwaho A, Burgess PI, Burton MJ, Chai J, Chilunga FP, Chipendo P, Conn A, Joel DR, Eagan AW, Gishoma C, Ho J, Jong S, Kakarmath SS, Khan Y, Kharel R, Kyle MA, Lee SC, Lichtman A, Malm CP, Mbaye MN, Muhimpundu MA, Mwagomba BM, Mwangi KJ, Nair M, Niyonsenga SP, Njuguna B, Okafor OLO, Okunade O, Park PH, Pastakia SD, Pekny C, Reja A, Rotimi CN, Rwunganira S, Sando D, Sarriera G, Sharma A, Sidibe A, Siraj ES, Syed AS, Van Acker K, Werfalli M.

Lancet Diabetes Endocrinol. 2017 Aug;5(8):622-667. doi: 10.1016/S2213-8587(17)30181-X. Epub 2017 Jul 5. Review. No abstract available.

PMID:
28688818
18.

Genomic ancestry and education level independently influence abdominal fat distributions in a Brazilian admixed population.

França GVA, De Lucia Rolfe E, Horta BL, Gigante DP, Yudkin JS, Ong KK, Victora CG.

PLoS One. 2017 Jun 5;12(6):e0179085. doi: 10.1371/journal.pone.0179085. eCollection 2017. Erratum in: PLoS One. 2018 Apr 17;13(4):e0196265.

19.

Essential medicines and access to insulin.

Gill G, Yudkin JS, Tesfaye S, de Courten M, Gale E, Motala A, Ramaiya K, Unwin N, Wild S.

Lancet Diabetes Endocrinol. 2017 May;5(5):324-325. doi: 10.1016/S2213-8587(17)30090-6. Epub 2017 Mar 18. No abstract available.

PMID:
28330591
20.

The association of hyperglycaemia with prevalent tuberculosis: a population-based cross-sectional study.

Bailey SL, Ayles H, Beyers N, Godfrey-Faussett P, Muyoyeta M, du Toit E, Yudkin JS, Floyd S.

BMC Infect Dis. 2016 Dec 5;16(1):733.

Supplemental Content

Loading ...
Support Center